Form 4: Twist Bioscience CEO Emily Leproust Sells Shares to Cover Tax Obligations
SEC Form 4
CEO of Twist Bioscience, Emily Leproust, sold 1,730 shares of common stock on September 20, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On September 20, 2024, Emily M. Leproust, CEO of Twist Bioscience, sold 1,730 shares of Twist Bioscience Corp (TWST) common stock at a price of $46.941 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- Following the transaction, Leproust directly owns 495,523 shares of Twist Bioscience Corp.
- Leproust also holds various employee stock options with different exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't necessarily indicate a change in the CEO's confidence in the company.
Industry Context
Insider sales are a common occurrence, especially to cover tax obligations related to equity compensation. The market typically analyzes the size and frequency of such sales to gauge insider sentiment.
Comparison to Industry Standards
- Comparing Leproust's stock ownership and option holdings to those of CEOs at comparable biotechnology companies like Ginkgo Bioworks or Amyris would provide a benchmark for assessing the magnitude of her stake.
- Analyzing the vesting schedules and exercise prices of her options relative to industry norms for executive compensation packages would offer further context.
- The 'sell to cover' practice is standard across many companies, including those in the biotech sector.
Stakeholder Impact
- The sale of shares may have a minor, short-term impact on shareholders due to the increased supply of shares in the market.
- However, since the sale is for tax obligations, it is unlikely to significantly affect long-term investor confidence.
Key Dates
| Date | Description |
|---|---|
| 09/01/2016 | 25% of shares subject to one employee stock option vested. |
| 09/28/2017 | 10% of shares subject to one employee stock option vested. |
| 09/28/2018 | 15% of shares subject to one employee stock option vested. |
| 10/31/2019 | 20% of shares subject to one employee stock option vested. |
| 09/01/2020 | Performance stock options granted to the reporting person. |
| 10/24/2020 | 25% of shares subject to one employee stock option vested. |
| 12/19/2022 | Performance stock options vested and became exercisable. |
| 09/20/2024 | Emily Leproust sold 1,730 shares of TWST common stock. |
| 09/24/2024 | Date of Form 4 filing. |
| 09/28/2025 | Expiration date for one employee stock option. |
| 09/28/2027 | Expiration date for one employee stock option. |
| 11/18/2028 | Expiration date for one employee stock option. |
| 10/23/2029 | Expiration date for one employee stock option. |
| 08/31/2030 | Expiration date for one employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.